Tagged with france

France Commission des Affaires Sociales de l’Assemblée Nationale (Commission of Social Affairs, National Assembly)   Key People: Brigitte Bourguignon, Chairwoman Olivier Véran, General Reporter The Social Affairs Committee of the National Assembly is one of the eight standing committees of the French National Assembly. The areas of competence of the Social Affairs Committee are…

France Joël Jaouen, president of France Alzheimer, provides important insights into the role and objectives of the patient association. He explains why France Alzheimer together with other learned societies filed a case with the State Council against the French Minister of Health & Solidarity.   Alzheimer’s scares. Why? Because it is…

France PharmaBoardroom’s list of personalities whose voices, opinions and decisions matter in French pharma’s industry, regulatory affairs, reimbursement and pricing.   Maurice-Pierre Planel — President of CEPS Maurice-Pierre Planel Has been heading the Economic Committee of Health Products (CEPS) since December 2015.   CEPS contributes to the development of pharmaceutical policy, implements…

France Lundbeck France and Benelux’s Lourdes Pla discusses Europe-wide restructuring, the importance of the French affiliate to the global group and the government’s attitude towards healthcare and neuroscience.   We are the only specialty pharma player exclusively dedicated to neuroscience and it is important that this shines through in our dealings…

France Gérard Raymond, president of the Fédération Francaise des Diabétiques (FFD – French Diabetes Federation), gives an update on the situation of diabetes in France and explains the challenges for patient associations in the country. He also shares his vision on how the FFD has to evolve to remain a relevant…

France Christophe Cizeron, president of Lyonbiopole, discusses the important economic and industrial position of the research cluster in the Rhone-Alps Region as well as the challenges posed by domestic and international competition.   Between 2007-2016, the number of biotech companies doubled in the Lyon region and there was a sharp increase…

France Vincent Leonhardt explains how the French administration’s zeal for life science innovation can actually place pressure on some pharma SMEs. He also discusses the challenges he faced during his first 2.5 years at the helm of Nordic Pharma in France.   Over the last decade, Nordic Pharma has gained renown…

France Pierre Moustial, CEO of URGO Group, explains the life-changing advancement in wound care treatments that URGO has been providing to patients all over the world as well as his upcoming plan to establish the company as a global leader by developing more innovative solutions in wound care and sleeping disorders.…

France Thomas Courbe, general director of the DGE (Direction Générale des Entreprises – General Directorate for Enterprises), speaks about the role of the DGE and the implementation of new policies oriented towards France’s new pro-business direction, specifically in the life sciences industry.   France is becoming the pro-business model in Europe.…

France Stéphane Roques, CEO of Medicen, the health care cluster for the Paris region, discusses his vision for Medicen and the changes he has made during his first few months in the tole. He highlights the need for domestic and European collaboration to be able to compete against clusters in the…

France Pierre Moustial, chairman of MedTech in France, the association of medical technology companies in France, discusses the challenges for French healthcare start-ups to scale-up and explains why France has no medtech champion despite the world-class innovation in the country.   In France, we do not have a problem getting start-ups…

France Frédérique Vidal, the French Minister of Higher Education, Research and Innovation, discusses her plans to create innovation campuses to facilitate the collaboration between industry, institutes and academia. She also highlights the importance of European collaboration in the fields of research and artificial intelligence.   I know first hand the importance…